2024 Working Groups Webinar Archive
Date | Working Group/Project | Title | Speakers | Recordings |
---|---|---|---|---|
18 January | RWD Quality Challenges – Different Perspectives
| Dr Cheryl Grandinetti, FDA and Kris Wenzel, MMS
| ||
1 February | Dataset-JSON Project Status Update
| Stuart Malcom, Veramed, Sam Hume, CDISC, Jesse Anderson, FDA, Marguerite Kolb, Johnson & Johnson and Nicole Thorne, BMS | ||
21 February | Vera Pomerantseva, ZS Associates
| |||
17 April
| Dr. Junshui Ma, Merck | |||
18 April | Michèle Arnoe, IQVIA, Jeffrey Brown, TriNetX and Benjamin Forred, Sanford Research | |||
26 April | Open Source – Solutions of the People, by the People, for the People | Michael Rimler, PHUSE Open Source Technologies Director | Meetings are not recorded. | |
17 May | Open Forum: Open Source in Pharma and Long-Term Dependability | Mike Smith, Pfizer | Meetings are not recorded. | |
14 June
| Open Forum: Open Source in Pharma, Regulatory Acceptance and Validation
| Mike Smith, Pfizer | Meetings are not recorded. | |
11 July | Understanding the Complete Journey of RWD, from Data Source to Final Analysis | Jean-Marc Ferran, Independent Consultant, Berber Snoeijer, Clinline and Ariel Berger, Evidera | ||
12 July | Open Forum: Regulatory Acceptance of Open-Source Submissions | Katja Glaß, Katja Glass Consulting | Meetings are not recorded. | |
13 September
| Open Forum: What is the True Cost of Open Source?
| Mike Stackhouse, Atorus Research
| Meetings are not recorded. | |
25 September
| Emerging Trends & Technologies
| Anindita Saha, FDA, MiRa Jacobs, FDA and Kausar Riaz Ahmed, Pfizer | ||
11 October | Open Forum: Open Source Technologies in Clinical Data Analysis | Michael Rimler, PHUSE Open Source Technologies Director | Meetings are not recorded. | |
24 October | RWD Sources – How the Genesis of Your Data Determines What Questions You Can Answer | Matthew Reynolds, Azimuth Research Group and Timothy Wolfe, Verantos | ||
20 November | Recommendations for Adverse Event Collection and Treatment Emergent Definition | Bill Palo, AbbVie and Aimee Basile, Otsuka | ||
21 November
| Lan Mu, University of Georgia, Jielu Zhang, University of Georgia, Marsha Samson, FDA and Jian Dai, Roche |